Clinical Trial Detail

NCT ID NCT02278120
Title Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer (MONALEESA-7)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements yes
Sponsors Novartis Pharmaceuticals
Indications

Her2-receptor negative breast cancer

Therapies

Goserelin + Ribociclib

Tamoxifen

Letrozole

Goserelin

Anastrozole

Age Groups: adult senior

Additional content available in CKB BOOST